New Technology Could Deliver Drugs to Brain Injuries
Peptide carries molecules and nanoparticles to acutely damaged areas of the brain
Most traumatic brain injuries (TBIs) occur as a result of car crashes, falls and violence. The initial TBI cannot be repaired. However, scientists feel they have found a technology that can limit the damaging effects patients could potentially encounter with a TBI. “We have found a sequence of four amino acids, cysteine, alanine, glutamine and lysine (CAQK), that recognizes injured brain tissue,” said Erkki Ruoslahti, MD, PhD, distinguished in SPB’s NCI-Designated Cancer Center and senior author of the study. “This peptide could be used to deliver treatments that limit the extent of damage.” To read more, click here.
Intraoperative Neurophysiology in Neurosurgery: The Essentials. 2nd Edition
Dec. 14-16, 2017; Verona, Italy
Mayo Clinic Neuroscience and Oncology Innovation Summit 2017
Dec. 14, 2017 - Dec. 16, 2017; Orlando, Fla.
43rd Annual Meeting of Louisiana Neurosurgical Society
Jan. 12, 2018 - Jan. 13, 2018; Shreveport, La.
2018 CANS Annual Meeting
Jan. 12-14, 2018; San Diego